© Copyright 2025 American Medical Association. All rights reserved.
Focused microwave therapy (FMT) is a specialized medical procedure designed for the destruction or reduction of malignant breast tumors. This technique utilizes externally applied focused microwave energy, which is particularly effective due to the unique properties of malignant breast tumor cells. These cells typically contain a higher water content compared to surrounding healthy breast tissue, making them more susceptible to damage from elevated temperatures. FMT can serve as either a primary treatment or an adjunctive therapy, especially for patients who may not be suitable candidates for traditional surgical options such as lumpectomy or mastectomy. The procedure is minimally invasive, often involving the use of local anesthetics to ensure patient comfort. During the treatment, a multiprobe catheter is inserted directly into the tumor under ultrasound guidance, allowing for precise targeting of the tumor. The patient is positioned on a modified stereotactic breast needle biopsy table, where the breast is compressed to facilitate the application of microwave energy. This method not only aims to destroy the tumor but may also enhance the effectiveness of subsequent radiation therapy and chemotherapy by sensitizing the tumor cells. The entire FMT process typically lasts between 20 to 30 minutes, concluding with the removal of the catheter and probes, followed by the application of a sterile dressing to the puncture sites.
© Copyright 2025 Coding Ahead. All rights reserved.
Focused microwave therapy (FMT) is indicated for the treatment of malignant breast tumors in patients who meet specific criteria. The following conditions may warrant the use of this procedure:
The procedure for focused microwave therapy (FMT) involves several critical steps to ensure effective treatment of malignant breast tumors. Each step is carefully executed to maximize the therapeutic outcome while minimizing discomfort for the patient.
After the focused microwave therapy (FMT) procedure, patients may experience some mild discomfort at the treatment site, which is typically manageable with over-the-counter pain relief. It is important for patients to follow any specific post-procedure care instructions provided by their healthcare provider. This may include keeping the dressing clean and dry, monitoring the puncture sites for signs of infection, and scheduling follow-up appointments to assess the treatment's effectiveness. Patients are generally advised to avoid strenuous activities for a short period following the procedure to allow for proper healing. The healthcare team will provide guidance on when normal activities can be resumed and any additional treatments that may be necessary as part of the overall cancer management plan.
Short Descr | MW THERAPY FOR BREAST TUMOR | Medium Descr | DEST/REDUC MALIG BRST TUMR W/US THRMORX GUIDANCE | Long Descr | Destruction/reduction of malignant breast tumor with externally applied focused microwave, including interstitial placement of disposable catheter with combined temperature monitoring probe and microwave focusing sensocatheter under ultrasound thermotherapy guidance | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | P1G - Major procedure - Other | MUE | Not applicable/unspecified. | CCS Clinical Classification | 166 - Lumpectomy, quadrantectomy of breast |
Date
|
Action
|
Notes
|
---|---|---|
2018-01-01 | Deleted | Code deleted, to report see 19499 |
2017-12-31 | Deleted | Code deleted, see 19499. |
2017-01-01 | Changed | Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category. |
2013-01-01 | Added | First appearance in code book |
2013-01-01 | Changed | Guideline information changed. |
2012-01-01 | Added | Added |
Get instant expert-level medical coding assistance.